Efficient Drug Development

TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.

Do you want to exchange knowledge?

Steven Erpelinck is happy to talk to you.

Contact me

Our latest developments

13 resultaten, getoond 1 t/m 5

Preclinical ADME

Informatietype:
Article
TNO is one of the only independent research and technology organisations in Europe to make preclinical in vitro and ex vivo tissue models available to drug developers and pharma companies, in order to enable faster, more accurate drug development.
Read more
over Preclinical ADME

TNO launches Peregrion to boost market impact of its technology that accelerates medicine development

Informatietype:
News
25 March 2024
Read more
over TNO launches Peregrion to boost market impact of its technology that accelerates medicine development

PPP uncovers new insights into MASLD development

Informatietype:
Insight
15 February 2024
Read more
over PPP uncovers new insights into MASLD development

Translational preclinical efficacy models

Informatietype:
Article
Read more
over Translational preclinical efficacy models

Time setters: reduce long waits for new medication with AMS

Informatietype:
Insight
10 August 2023
Read more
over Time setters: reduce long waits for new medication with AMS